ASX - By Stock
|
QUB |
Re:
Ann: Half Year Investor Presentation
|
|
Gareth
|
5 |
1.1K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
5
|
1.1K
|
1
|
|
ASX - By Stock
|
MVF |
Re:
Ann: S&P DJI Announces March 2024 Quarterly Rebalance
|
|
Gareth
|
4 |
1.1K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
GDC |
Re:
Airtrunk
|
|
Gareth
|
7 |
1.4K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
7
|
1.4K
|
1
|
|
ASX - By Stock
|
GDC |
Re:
Airtrunk
|
|
Gareth
|
7 |
1.4K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
7
|
1.4K
|
0
|
|
ASX - By Stock
|
LNK |
Re:
Ann: Update on status of Conditions Precedent & ATO Draft Ruling
|
|
Gareth
|
27 |
5.2K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
27
|
5.2K
|
1
|
|
ASX - By Stock
|
LNK |
Re:
Ann: Update on status of Conditions Precedent & ATO Draft Ruling
|
|
Gareth
|
27 |
5.2K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
27
|
5.2K
|
2
|
|
ASX - By Stock
|
LNK |
Re:
Ann: Update on status of Conditions Precedent & ATO Draft Ruling
|
|
Gareth
|
27 |
5.2K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
27
|
5.2K
|
2
|
|
ASX - By Stock
|
AOF |
Re:
Ann: Sale of 150 Charlotte Street Brisbane
|
|
Gareth
|
6 |
997 |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
6
|
997
|
0
|
|
ASX - By Stock
|
KPG |
Re:
Future of KPG $6 and beyond
|
|
Gareth
|
9 |
4.1K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
9
|
4.1K
|
1
|
|
Charts
|
EMV |
Re:
Chart
|
|
Gareth
|
2.7K |
1.5M |
3 |
19/04/24 |
19/04/24 |
Charts
|
2.7K
|
1.5M
|
3
|
|
Charts
|
EMV |
Re:
Chart
|
|
Gareth
|
2.7K |
1.5M |
5 |
19/04/24 |
19/04/24 |
Charts
|
2.7K
|
1.5M
|
5
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
Gareth
|
58 |
13K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
58
|
13K
|
3
|
|
ASX - By Stock
|
RMD Medicine |
Re:
Buy RMD now and get great upside returns in a year or two
|
|
Gareth
|
189 |
106K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
189
|
106K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Gareth
|
2.4K |
1.1M |
6 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
Gareth
|
58 |
13K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
58
|
13K
|
4
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Proposed issue of securities - MX1
|
|
Gareth
|
9 |
3.9K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
9
|
3.9K
|
0
|
|
Charts
|
EMV |
Re:
Chart
|
|
Gareth
|
2.7K |
1.5M |
1 |
16/04/24 |
16/04/24 |
Charts
|
2.7K
|
1.5M
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
Gareth
|
58 |
13K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
58
|
13K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
Gareth
|
14 |
4.7K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
14
|
4.7K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
Gareth
|
14 |
4.7K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
14
|
4.7K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Gareth
|
2.4K |
1.1M |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
5
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Gareth
|
2.4K |
1.1M |
7 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
7
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Gareth
|
72 |
20K |
4 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
72
|
20K
|
4
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
Gareth
|
58 |
13K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
58
|
13K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Gareth
|
72 |
20K |
3 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
72
|
20K
|
3
|
|
ASX - By Stock
|
ASH |
Re:
Are the BOTs here?
|
|
Gareth
|
9 |
1.5K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
1.5K
|
0
|
|
ASX - By Stock
|
ASH |
Re:
Are the BOTs here?
|
|
Gareth
|
9 |
1.5K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
1.5K
|
0
|
|
Charts
|
EMV |
Re:
Chart
|
|
Gareth
|
2.7K |
1.5M |
0 |
09/04/24 |
09/04/24 |
Charts
|
2.7K
|
1.5M
|
0
|
|
ASX - By Stock
|
PXA |
PXA Cost base from LNK
|
|
Gareth
|
1 |
590 |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1
|
590
|
2
|
|
ASX - By Stock
|
PXA |
Re:
Ann: FY24 Half Year Results Presentation
|
|
Gareth
|
29 |
10K |
3 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
29
|
10K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
10 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
46
|
16K
|
10
|
|
ASX - By Stock
|
LM8 |
Re:
Ann: Gold Success at Foster-Baker
|
|
Gareth
|
4 |
1.5K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
46
|
16K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
46
|
16K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
46
|
16K
|
0
|
|
ASX - By Stock
|
5GN |
Re:
Ann: Notification of cessation of securities - 5GN
|
|
Gareth
|
10 |
3.6K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
10
|
3.6K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
46
|
16K
|
2
|
|
ASX - By Stock
|
PXA |
Re:
Ann: FY24 Half Year Results Presentation
|
|
Gareth
|
29 |
10K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
29
|
10K
|
1
|
|
ASX - By Stock
|
PXA |
Re:
Ann: FY24 Half Year Results Presentation
|
|
Gareth
|
29 |
10K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
29
|
10K
|
1
|
|
ASX - By Stock
|
IDX |
Re:
Ann: Half Year Results Investor Presentation
|
|
Gareth
|
11 |
6.1K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
11
|
6.1K
|
0
|
|
ASX - By Stock
|
URF |
Re:
Ann: Weekly NAV Estimate
|
|
Gareth
|
7 |
2.7K |
1 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
7
|
2.7K
|
1
|
|
ASX - By Stock
|
URF |
Re:
Ann: Weekly NAV Estimate
|
|
Gareth
|
7 |
2.7K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
7
|
2.7K
|
0
|
|
ASX - By Stock
|
LNK |
Re:
Ann: Court Approves Convening of Scheme Meeting
|
|
Gareth
|
22 |
7.2K |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
22
|
7.2K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Media
|
|
Gareth
|
55 |
22K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
55
|
22K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Gareth
|
46 |
16K |
13 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
13
|
|